½ÃÀ庸°í¼­
»óǰÄÚµå
1775320

Àúħ½À ¿µ»ó Áø´Ü ½ÃÀå : ¿¹Ãø(2025-2030³â)

Minimally Invasive Imaging Market - Forecasts from 2025 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Knowledge Sourcing Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 145 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Àúħ½À ¿µ»ó Áø´Ü ½ÃÀåÀº CAGR 5.15%·Î, 2025³â 244¾ï 8,400¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 314¾ï 7,400¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Àúħ½ÀÀû ¿µ»ó Áø´Ü ¼¼°è ½ÃÀåÀº ÀÇ·á±â±âÀÇ ±â¼úÀû Áøº¸·Î ÀÎÇØ È¿À²¼º Çâ»ó, Áúº´ ¹ß°ß °¡¼ÓÈ­, Áø´Ü ÇÁ·Î¼¼½º °³¼±, ȯÀÚ ¸ð´ÏÅ͸µÀÇ »ý»ê¼º Çâ»ó¿¡ ÈûÀÔ¾î °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â ¾ö°ÝÇÑ ¿ÀÅäŬ·¹ÀÌºê ±ÔÁ¦, Àúħ½ÀÀû ¿µ»ó Áø´Ü ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °ø°ø ¹× ¹Î°£ÀÇ ÀÇ·á ÅõÀÚ È®´ë¿Í ¿¹¹æ ÀÇ·á ¹× Á¶±â Áúº´ °³ÀÔÀ¸·ÎÀÇ ÀüȯÀÌ ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀº ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡¿Í ³ëÀÎ Àα¸ Áõ°¡·Î ÀÎÇØ Å« ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â ³ëÀÎ Àα¸ÀÇ 80%°¡ Àû¾îµµ ÇÑ °¡Áö ÀÌ»óÀÇ ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖÀ¸¸ç, ¹Ì±¹ ÀÇ»çÇùȸÀÇ ¿¹Ãø¿¡ µû¸£¸é 2030³â±îÁö 65¼¼ ÀÌ»ó ³ëÀÎÀÇ 60% ÀÌ»óÀÌ ¿©·¯ °¡Áö ¸¸¼ºÁúȯÀ» ¾Î°Ô µÉ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. ¾ËÃ÷ÇÏÀ̸Ӻ´, °üÀý¿°, ÆÄŲ½¼º´, Ä¡¸Å, ¾Ï, ½ÉÇ÷°ü Áúȯ µî ³ëÈ­ °ü·Ã ÁúȯÀÇ ¹ß»ý·üÀº Àü ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿¡ µû¶ó Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó °í±Þ Ä¡·á ¿É¼Ç, °³¼±µÈ ÀÇ·á½Ã¼³, ÷´Ü ¿µ»ó ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±×·¯³ª Àúħ½ÀÀû ¿µ»ó Áø´Ü ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ë, ¼÷·ÃµÈ ±â¼úÀÚ ºÎÁ·, º¹ÀâÇÑ °Ë»ç ÇÁ·ÎÅäÄÝÀ» °ü¸®ÇÏ´Â Á¤ºÎÀÇ ¾ö°ÝÇÑ ±ÔÁ¦ µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ Æ¯Á¤ ¿µ»ó ¾ç½ÄÀÇ ±â¼úÀû ÇѰ赵 ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î CT ½ºÄµÀº ¿¬Á¶Á÷ ´ëºñ°¡ ³·°í, ±â´ÉÀû Á¤º¸°¡ Á¦ÇÑÀûÀ̸ç, ȯÀÚ¿Í ÀÇ·áÁøÀÌ ¹æ»ç¼±¿¡ ³ëÃâµÇ¹Ç·Î ÀÌ·¯ÇÑ ½Ã½ºÅÛ¿¡ ´ëÇÑ ÅõÀÚ¸¦ ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­ ºÐ¼®

½Ã½ºÅÛº°: ½ÃÀåÀº ÃÊÀ½ÆÄ, CT, ¿¢½º·¹ÀÌ, MRI, ±âŸ ¸ð´Þ¸®Æ¼·Î ±¸ºÐµÇ¸ç, ¿¢½º·¹ÀÌ ºÎ¹®Àº Á÷Á¢ ¿¢½º·¹ÀÌ ÃÔ¿µÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿ìÀ§¸¦ Á¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ ÃÊÀ½ÆÄ °Ë»ç´Â ºñħ½ÀÀûÀÌ°í ´Ù¿ëµµÇÏ´Ù´Â ÀåÁ¡À¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°: ½ÃÀåÀº Áø´Ü¼¾ÅÍ, º´¿ø, Àü¹® Ŭ¸®´Ð ¹× ¿¬±¸¼¾ÅÍ¿Í °°Àº ±âŸ ½Ã¼³·Î ±¸ºÐµÇ¸ç, MRI ¹× CT ½ºÄ³³Ê¿Í °°Àº °í±Þ ¿µ»ó Áø´Ü ¾ç½Ä¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô±â ¶§¹®¿¡ º´¿øÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º´¿øÀº ÃÖ÷´Ü ¿µ»ó ó¸® ±â¼ú°ú ¼÷·ÃµÈ ÀÇ·á Àü¹®°¡¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖÀ¸¹Ç·Î ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

  • ½ÃÀå ¼¼ºÐÈ­
  • ½ÃÀåÀº ºÏ¹Ì, ¾Æ½Ã¾ÆÅÂÆò¾ç, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ³²¹Ì·Î ±¸ºÐµË´Ï´Ù. ºÏ¹Ì´Â ÷´Ü ÀÇ·á ÀÎÇÁ¶ó, dzºÎÇÑ R&D ÅõÀÚ, ÀÇ·á ½Ã½ºÅÛ Çö´ëÈ­¸¦ À§ÇÑ ¹Ì±¹ Á¤ºÎÀÇ ±¸»ó¿¡ ÈûÀÔ¾î Å« ½ÃÀå Á¡À¯À²À» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àεµ¿Í °°Àº ±¹°¡µéÀÇ ÀÇ·á °ü±¤ È®´ë¿Í °í·É Àα¸ Áõ°¡·Î ÀÎÇÑ Ã·´Ü ¿µ»ó ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • °á·ÐÀûÀ¸·Î Àúħ½À ¿µ»ó Áø´Ü ½ÃÀåÀº ³ôÀº ºñ¿ë°ú ±ÔÁ¦ À庮°ú °°Àº °úÁ¦´Â ³²¾ÆÀÖÁö¸¸, ±â¼ú ¹ßÀü, Àα¸ µ¿Çâ, ÀÇ·á ÅõÀÚ°¡ ¿øµ¿·ÂÀÌ µÇ¾î Å« ÆøÀÇ ¼ºÀåÀÌ ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÁÖ¿ä ÀåÁ¡

  • ÀλçÀÌÆ® ºÐ¼® : °í°´ ºÎ¹®, Á¤ºÎ Á¤Ã¥ ¹× »çȸ°æÁ¦Àû ¿äÀÎ, ¼ÒºñÀÚ ¼±È£µµ, »ê¾÷º°, ±âŸ ÇÏÀ§ ºÎ¹®¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÁÖ¿ä Áö¿ª»Ó¸¸ ¾Æ´Ï¶ó ½ÅÈï Áö¿ª±îÁö Æ÷°ýÇÏ´Â »ó¼¼ÇÑ ½ÃÀå ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.
  • °æÀï ±¸µµ: ¼¼°è ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇϰí ÀÖ´Â Àü·«Àû Àü·«À» ÀÌÇØÇϰí, ÀûÀýÇÑ Àü·«À» ÅëÇÑ ½ÃÀå ħÅõ °¡´É¼ºÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú ¹Ì·¡ µ¿Çâ : ¿ªµ¿ÀûÀÎ ¿äÀΰú ¸Å¿ì Áß¿äÇÑ ½ÃÀå µ¿Çâ, ±×¸®°í À̵éÀÌ ÇâÈÄ ½ÃÀå ¹ßÀüÀ» ¾î¶»°Ô Çü¼ºÇÒ °ÍÀÎÁö¿¡ ´ëÇØ ¾Ë¾Æº¾´Ï´Ù.
  • ½ÇÇà °¡´ÉÇÑ Á¦¾È: ¿ªµ¿ÀûÀΠȯ°æ ¼Ó¿¡¼­ »õ·Î¿î ºñÁî´Ï½º ½ºÆ®¸²°ú ¸ÅÃâÀ» ¹ß±¼Çϱâ À§ÇÑ Àü·«Àû ÀÇ»ç°áÁ¤¿¡ ÀλçÀÌÆ®¸¦ Ȱ¿ëÇÕ´Ï´Ù.
  • ´Ù¾çÇÑ »ç¿ëÀÚ¿¡ ´ëÀÀ: ½ºÅ¸Æ®¾÷, ¿¬±¸±â°ü, ÄÁ¼³ÅÏÆ®, Áß¼Ò±â¾÷, ´ë±â¾÷¿¡ À¯ÀÍÇÏ°í ºñ¿ë È¿À²ÀûÀÔ´Ï´Ù.

ºÐ¼® ¹üÀ§

  • °ú°Å µ¥ÀÌÅÍ(2022-2024³â) ¹× ¿¹Ãø µ¥ÀÌÅÍ(2025-2030³â)
  • ¼ºÀå ±âȸ, °úÁ¦, °ø±Þ¸Á Àü¸Á, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, °í°´ Çൿ, µ¿Ç⠺м®
  • °æÀï»ç Æ÷Áö¼Å´×, Àü·« ¹× ½ÃÀå Á¡À¯À² ºÐ¼®
  • ¸ÅÃâ ¼ºÀå·ü ¹× ¿¹Ãø ºÐ¼® : ºÎ¹®º°/Áö¿ªº°(±¹°¡º°)
  • ±â¾÷ ÇÁ·ÎÆÄÀϸµ(Àü·«, Á¦Ç°, À繫Á¤º¸, ÁÖ¿ä µ¿Çâ µî)

¿µ»ó Áø´Ü À¯Çüº°

  • ÃÊÀ½ÆÄ
  • ÀÚ±â°ø¸í¿µ»ó(MRI)
  • ¿¢½º·¹ÀÌ
  • ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT)
  • ±âŸ

¿ëµµº°

  • ¼øÈ¯±â³»°ú
  • ½Å°æ°ú
  • Á¾¾ç°ú
  • Á¤Çü¿Ü°ú
  • ±âŸ

ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ
  • ¿µ»ó Áø´Ü¼¾ÅÍ
  • ±âŸ

Áö¿ªº°

  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ³²¹Ì
  • ºê¶óÁú
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÇÁ¶û½º
  • ÀÌÅ»¸®¾Æ
  • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • À̽º¶ó¿¤
  • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • ÀϺ»
  • Àεµ
  • Çѱ¹
  • Àεµ³×½Ã¾Æ
  • ű¹
  • ´ë¸¸
  • ±âŸ

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå ½º³À¼ô

  • ½ÃÀå °³¿ä
  • ½ÃÀåÀÇ Á¤ÀÇ
  • ºÐ¼® ¹üÀ§
  • ½ÃÀå ¼¼ºÐÈ­

Á¦3Àå ºñÁî´Ï½º »óȲ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • Porter's Five Forces ºÐ¼®
  • ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
  • Á¤Ã¥°ú ±ÔÁ¦
  • Àü·«Àû Á¦¾È

Á¦4Àå ±â¼ú Àü¸Á

Á¦5Àå ¼¼°èÀÇ Àúħ½À ¿µ»ó Áø´Ü ½ÃÀå : ¿µ»ó Áø´Ü À¯Çüº°

  • ¼­·Ð
  • ÃÊÀ½ÆÄ
  • ÀÚ±â°ø¸í¿µ»ó(MRI)
  • X¼±
  • ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT)
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ Àúħ½À ¿µ»ó Áø´Ü ½ÃÀå : ¿ëµµº°

  • ¼­·Ð
  • ¼øÈ¯±â°ú
  • ½Å°æ°ú
  • Á¾¾ç°ú
  • Á¤Çü¿Ü°ú
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ Àúħ½À ¿µ»ó Áø´Ü ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ¿µ»ó Áø´Ü ¼¾ÅÍ
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ Àúħ½À ¿µ»ó Áø´Ü ½ÃÀå : Áö¿ªº°

  • ¼­·Ð
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ½ºÆäÀÎ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • Àεµ³×½Ã¾Æ
    • ű¹
    • ±âŸ

Á¦9Àå °æÀï ȯ°æ°ú ºÐ¼®

  • ÁÖ¿ä ±â¾÷°ú Àü·« ºÐ¼®
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ±â¾÷ÀμöÇÕº´(M&A), ÇÕÀÇ, »ç¾÷ Çù·Â
  • °æÀï ´ë½Ãº¸µå

Á¦10Àå ±â¾÷ °³¿ä

  • Hitachi High-Tech Corporation
  • GE Healthcare
  • Boston Scientific Corporation
  • Medtronic Plc
  • Koninklijke Philips N.V.
  • Canon Inc.
  • Carestream Health
  • Trivitron Healthcare
  • FUJIFILM Corporation.
  • Siemens Healthineers

Á¦11Àå ºÎ·Ï

  • ÅëÈ­
  • ÀüÁ¦Á¶°Ç
  • ±âÁØ¿¬µµ¿Í ¿¹Ãø¿¬µµ ŸÀÓ¶óÀÎ
  • ÀÌÇØ°ü°èÀÚ¿¡ ´ëÇÑ ÁÖ¿ä ÀÌÁ¡
  • ºÐ¼® ¹æ¹ý
  • ¾à¾î
KSA 25.07.30

The global minimally invasive imaging market is expected to grow from USD 24.484 billion in 2025 to USD 31.474 billion in 2030, at a CAGR of 5.15%.

The global minimally invasive imaging market is experiencing robust growth driven by technological advancements in medical devices, which enhance efficiency, accelerate disease detection, improve diagnostic processes, and boost productivity in patient monitoring. Key drivers include stringent autoclaving regulations, rising demand for minimally invasive imaging systems, and the increasing prevalence of chronic disorders. Additionally, growing investments in healthcare from public and private sectors, coupled with a shift toward preventive healthcare and early disease intervention, are propelling market expansion.

The market is significantly influenced by the rising prevalence of chronic diseases and the expanding geriatric population. In the U.S., the Centers for Disease Control and Prevention notes that nearly 80% of elderly individuals have at least one chronic condition, with projections from the American Medical Association indicating that by 2030, over 60% of those aged 65 and older will have multiple chronic illnesses. The growing incidence of age-related conditions such as Alzheimer's, arthritis, Parkinson's, dementia, cancer, and cardiovascular diseases, fueled by an aging global population, is increasing the demand for advanced treatment options, improved healthcare facilities, and sophisticated imaging systems.

However, the market faces challenges, including the high cost of minimally invasive imaging systems, a shortage of skilled technicians, and stringent government regulations governing complex testing protocols. Technical limitations of certain imaging modalities also hinder growth. For example, CT scans offer poor soft-tissue contrast, provide limited functional information, and expose patients and healthcare providers to radiation, which discourages investment in these systems.

Market Segmentation Analysis

By System: The market is segmented into ultrasound, CT, X-ray, MRI, and other modalities. The X-ray segment is poised to dominate due to the increasing adoption of direct radiography. The ultrasound segment is also expected to see significant growth during the forecast period due to its non-invasive nature and versatility.

By End-Users: The market is divided into diagnostic centers, hospitals, and other facilities such as specialty clinics and research centers. Hospitals are expected to hold the largest market share, driven by the high demand for advanced imaging modalities like MRI and CT scanners for precise diagnostics during procedures. Hospitals' access to cutting-edge imaging technology and skilled healthcare professionals further supports market growth.

  • Geographical Outlook
  • The market is segmented into North America, Asia Pacific, Europe, the Middle East and Africa, and South America. North America is projected to maintain a significant market share, driven by advanced healthcare infrastructure, substantial R&D investments, and U.S. government initiatives to modernize healthcare systems. The Asia Pacific region is anticipated to experience rapid growth, fueled by expanding medical tourism in countries like India and a growing geriatric population, which increases demand for advanced imaging solutions.
  • In summary, the minimally invasive imaging market is poised for significant growth, driven by technological advancements, demographic trends, and healthcare investments, though challenges like high costs and regulatory hurdles persist.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
  • What do businesses use our reports for?
  • Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

By Imaging Type

  • Ultrasound
  • Magnetic Resonance Imaging (MRI)
  • X-Ray
  • Computed Tomography (CT)
  • Other

By Application

  • Cardiology
  • Neurology
  • Oncology
  • Orthopedics
  • Others

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • iddle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL MINIMALLY INVASIVE IMAGING MARKET BY IMAGING TYPE

  • 5.1. Introduction
  • 5.2. Ultrasound
  • 5.3. Magnetic Resonance Imaging (MRI)
  • 5.4. X-Ray
  • 5.5. Computed Tomography (CT)
  • 5.6. Others

6. GLOBAL MINIMALLY INVASIVE IMAGING MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Cardiology
  • 6.3. Neurology
  • 6.4. Oncology
  • 6.5. Orthopedics
  • 6.6. Others

7. GLOBAL MINIMALLY INVASIVE IMAGING MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Diagnostic Imaging Centers
  • 7.5. Others

8. GLOBAL MINIMALLY INVASIVE IMAGING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Hitachi High-Tech Corporation
  • 10.2. GE Healthcare
  • 10.3. Boston Scientific Corporation
  • 10.4. Medtronic Plc
  • 10.5. Koninklijke Philips N.V.
  • 10.6. Canon Inc.
  • 10.7. Carestream Health
  • 10.8. Trivitron Healthcare
  • 10.9. FUJIFILM Corporation.
  • 10.10. Siemens Healthineers

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦